CLL cells cultured under hypoxic conditions acquire a B-regulatory phenotype as defined by a marked upregulation of IL-10 [117], that is prevented upon A2A antagonist, thus confirming that in CLL microenvironment hypoxia and ADO function in a common signaling axis [3] (Figure 3). This evidence concerns the gene ADO and B-cell chronic lymphocytic leukemia.